Background: The mechanisms underlying food choices are complex and involve neuroendocrine and biochemical signaling. Among neuroendocrine signals, leptin may play a prominent role in food preference. Objective: This study was designed to obtain an understanding of the effects of leptin replacement on macro-and micronutrient preferences in leptin-deficient adults. Design: We studied the effects of leptin replacement on three adults with genetic leptin deficiency during the initial 12 months of treatment. Dietary intake was measured in our study by weighed food consumption records. Nutrient intake was calculated using a nutrition analysis software. Results: After leptin replacement was started, all patients had initially a marked reduction in food intake. The reduction in caloric intake differentially affected intake of macro-and micronutrients. There was an initial shift toward a higher percentage consumption of fats and a decrease in the intake of carbohydrates. Significant differences also occurred in 7 distinct types of macronutrients, 12 vitamins, 11 minerals and 1 amino acid. Conclusions: We documented several specific leptin-induced changes in macro-and micronutrients intake during the course of leptin-replacement treatment, the majority of which were not related to the decrease in total caloric consumption.
Introduction
Replacement therapy with recombinant methionyl human leptin (r-metHuLeptin) has been described to dramatically reduce the weight of obese individuals with genetically based leptin deficiency. 1, 2 In an earlier report we showed that food intake and body weight were significantly reduced after the initiation of leptin-replacement therapy in three leptindeficient adults who had been morbidly obese from two to four decades before the initiation of treatment. 1 We report in this article unpublished data on the intake of macro-and micronutrients of these patients after the start of leptinreplacement therapy.
Subjects and methods
We studied the effects of leptin replacement on these three leptin-deficient adults who are members of a highly consanguineous Turkish pedigree. Two women and one man have a Mendelian recessive nonconservative missense leptin gene mutation (Cys-to-Thr in codon 105) resulting in a leptin molecule that has the same amino acid substitution as that of the ob/ob mouse. Detailed phenotype and study protocol were previously described. 1, 3 Doses of r-metHuLeptin were designed to achieve a normal leptin concentration based on body fat of 30% in women and 20% in men. Administration was, therefore, started at low physiological doses and decreased gradually as patients lost weight to avoid excessive weight loss. Dosage ranged from 0.01 to 0.04 mg/kg. In this report we present the results of the nutritional intake data collected during the initial 12 months of leptin-replacement treatment.
Patients were flown from Turkey to the United States and stayed at the UCLA GCRC, facilities for the entire period described here. The study protocol started with a 2-month baseline assessment period, designed to deal with confounding factors related to time zone changes and potential alterations in food choice. After this period, leptin-replacement therapy was started. The last two weeks of the baseline period is called from now on visit 1 and provides the baseline data for the period before leptin-replacement initiation. Each subsequent visit data point is the average of daily assessments of consecutive 2-week periods.
The participants themselves selected foods ad lib from menus. All food and beverage provided to the study subjects were then recorded by weight with a precision balance. Nutrient intake was calculated using a nutrition analysis software (NutritionistPro, First DataBank Inc., San Bruno, CA, USA), which bases its analyses on a comprehensive database of over 18 000 foods and ingredients.
Analysis of variance with repeated measures was performed to test the significant differences over time for each of the nutritional variables. Pearson's correlation was performed to test for the correlation between total caloric intake and fat percentage and nutrients across the visits. A significance level of 0.05 was used. Post hoc test was performed using Tukey's multiple comparison test. Analyses were performed using Prism 4.0 (GraphPad Software Inc., San Diego, CA, USA), StatView 1.1 (Abacus Concepts Inc., Berkeley, CA, USA) and SAS 9.3.1 (SAS Institute Inc., Cary, NC, USA).
Results
After leptin replacement was started, all patients initially had a marked reduction in food intake. The mean daily caloric intake dropped 50%, from 23847946 kcal/day at baseline (visit 1) to 1179790 kcal at visit 2. After the initiation of leptin replacement, daily caloric intake decreased, reaching a nadir at 4-6 months, and thereafter it increased and became stable. 1 The effects of 18 months leptin replacement on body weight and body fat percentage, along with the levels of fasting glucose, insulin, cholesterol, apolipoprotein and C-peptide were described previously. 1 The reduction in caloric intake affected macro-and micronutrients intake differently during the first 12 months of follow-up ( Figure 1 ). Seven macronutrients showed significant differences between the visits, namely, cholesterol, polyunsaturated fatty acid (PFA) 18:2 linoleic acid, PFA 18:3 linolenic acid, PFA 20:5 eicosapentanoic acid (EPA), PFA 22:6 docosahexanoic acid (DHA), dietary fiber and sugar. The macronutrients that did not show differences were saturated fat, monounsaturated fat, polyunsaturated fat and oleic (monounsaturated fatty acidFMFA 18:1). The vitamins that showed differences were vitamin A, C, D and K, b-carotene, a-tocopherol, riboflavin, pyridoxine, folate, cobalamin, biotin and pantothenic acid. Vitamin E, thiamin and niacin did not change across the visits. All of the studied minerals (except selenium) showed differences between the visits, namely, sodium, potassium, calcium, iron, phosphorus, magnesium, zinc, copper, manganese, chromium and molybdenum. The studied amino acids were tryptophan, threonine, isoleucine, leucine, lysine, methionine, cystine, phenylalanine, tyrosine, valine and histidine. Among them there was only for tyrosine a significant difference between the visits. The magnitude of these changes and their temporal patterns are displayed in detail in Table 1 . Our data showed a strong positive correlation between fat percentage and linoleic acid (PFA 18:2) (r ¼ 0.998, P ¼ 0.039) in visit 3, and between fat percentage and cholesterol (r ¼ 1.00, P ¼ 0.0007), monounsaturated fat (r ¼ 0.999, P ¼ 0.009) and oleic acid (MFA 10: 1) (r ¼ 0.997, P ¼ 0.043) in visit 4. In the majority of the studied nutrients that showed changes across the visits the ratio of each nutrient to total caloric intake of the nutrients does not correlate (P40.05) with the total caloric intake. These are b-carotene, vitamin D, a-tocopherol, folate, cobalamin, biotin, sodium, iron, copper, manganese, chromium, cholesterol, linoleic acid, dietary fiber and total sugar. Moreover, changes in the ratios of vitamin A (r ¼ À0.58, P ¼ 0.0004), riboflavin (r ¼ À0.42, P ¼ 0.02), pantotenic acid (r ¼ À0.47, P ¼ 0.006), calcium (r ¼ À0.48, P ¼ 0.004), phosphorus (r ¼ À0.58, P ¼ 0.0004), EPA (r ¼ À0.39, P ¼ 0.02) and DHA (r ¼ À0.34, P ¼ 0.05), correlated with the drop in the total caloric intake.
Discussion
In this study we analyzed dietary data carried throughout an extended period of time following the initiation of leptinreplacement treatment in a group of leptin naive individuals. In a previous report 1 we clearly showed marked weight loss and decrease in body mass index following the initiation of leptin replacement in these patients. Leptin replacement brought about a transitory decrease of 50% in total caloric intake, and after this initial drop the caloric intake gradually increased and reached pretreatment levels, but weight loss continued for several months in the context of increased energy expenditure. 4 We showed here that the observed reduction in caloric intake differentially affected nutritional content. Our data reflects an increased percentage of dietary fat intake, particularly on visits 3-5 (months 2-6). Our study also showed a strong positive correlation between fat percentage and linoleic acid in visit 3, and between fat percentage and cholesterol, monounsaturated fat and oleic acid (MFA 10:1) in visit 4. These strong correlations support that, on those visits, the fat percentage increased due to the Leptin replacement on nutrient choices J Licinio et al increased dietary intake of foods that were good sources of these four lipids. Analysis of dietary records and nutrient content of consumed foods revealed that on visit 3, patients ate foods higher in linoleic acid such as baked chicken and mayonnaise. And on visit 4 they consumed more high fat foods such as sausage, pizza, cheese, dairy creamer and cooking oil. It is important to mention that these foods were available during the entire treatment period, but the patients only started to select them after the initiation of leptin replacement. This increase in fat percentage intake occurred at the expense of a diminished consumption of carbohydrates. Wetzler et al.
5 studied self-selecting rats on their choices of macronutrients before and after leptin administration, and found similar changes in the proportional intake of fat and carbohydrates. One possible explanation for this finding is that the increase in plasma leptin concentration inhibits insulin secretion, 6 increasing insulin sensitivity. 1 It has been proposed that such leptin-induced reduction of circulating insulin hinders the metabolism of a high-carbohydrate intake, so that high carbohydrate eaters would be compelled to reduce its intake and increase the ingestion of fat to meet their energy requirements. 7 Despite the caloric intake decrease, the consumption of amino acids and the percent protein intake did not change across the visits, and the patients chose a dietary profile that preserved their necessary amino acid load. We also show that while ingestion of some macro-and micronutrients did not change across the visits, ingestion of several others changed after initiation of leptin-replacement treatment. The majority of these changes do not correlate with changes of total caloric intake, which means that they are not due to the global decrease in caloric consumption, but rather reflect a modification in the profile of food intake, possibly due to a change in food preferences. These preferential changes occurred with b-carotene, vitamin D, a-tocopherol, folate, cobalamin, biotin, sodium, iron, copper, manganese, chromium, cholesterol, PFA 18:3, dietary fiber and total sugar. The changes in nutrient intake that could be explained by the decrease in total caloric intake, being correlated with changes in total caloric intake, were those seen with vitamin A, riboflavin, pantotenic acid, calcium, phosphorus, EPA and DHA.
Sample size represents an important limitation of this study. However, the extremely rare occurrence of genetic leptin deficiency prevents the study of more individuals. These patients provide us with an unmatched opportunity to understand the effects of leptin treatment on macro-and micronutrient food choices.
Little is known about the determinants of nutrient preferences in humans and it is unclear which factors influence the choice of macro-and micronutrients. Published work is mostly focused on the effects of different types of nutrients on serum leptin concentration. In contrast, our study assesses changes in food preference that occur when leptin is administered. This unique data set supports the concept that leptin influences distinct choices of nutrients. These include specific changes in the intake of micronutrients that corroborate the concept that leptin induces at the macronutrient level a shift toward a higher percent consumption of fats and a decrease in the intake of carbohydrates.
